MCM
PDSB icon

Militia Capital Management’s PDS Biotechnology PDSB Stock Holding History

Militia Capital Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Buy
+331,800
New +$352K 0.01% 260

Other funds holding PDSB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Militia Capital Management's PDSB Position: Q2 2026 in Review

Militia Capital Management opened a new position in PDS Biotechnology (PDSB) in Q2 2026: 331,800 shares worth $292K. The stake represents 0.01% of the portfolio and ranks #260 among its holdings.

35 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Militia Capital Management held 331,800 shares of PDS Biotechnology worth $292K as of Q2 2026.
  • PDS Biotechnology was a new Militia Capital Management position in Q2 2026.
  • PDS Biotechnology made up 0.01% of Militia Capital Management's portfolio in Q2 2026, its #260 holding.
  • 35 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Militia Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.